$STOK
Stoke Therapeutics, Inc.

2021 Q3 Form 10-Q Financial Statement

#000156459021055240 Filed on November 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q4 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.325M $5.680M $5.600M
YoY Change 48.66% 42.71% 68.67%
% of Gross Profit
Research & Development $14.36M $8.900M $8.110M
YoY Change 77.04% 25.53% 24.42%
% of Gross Profit
Depreciation & Amortization $254.0K $240.0K $230.0K
YoY Change 10.43% 71.43% 91.67%
% of Gross Profit
Operating Expenses $22.68M $14.59M $13.71M
YoY Change 65.44% 31.77% 39.31%
Operating Profit -$22.68M -$14.59M -$13.71M
YoY Change 65.44% 31.77% 39.31%
Interest Expense $44.00K $10.00K $10.00K
YoY Change 340.0% -98.89% -99.19%
% of Operating Profit
Other Income/Expense, Net $42.00K $20.00K $20.00K
YoY Change 110.0%
Pretax Income -$22.60M -$14.56M -$13.68M
YoY Change 65.18% 43.31% 59.07%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$22.60M -$14.56M -$13.68M
YoY Change 65.13% 43.32% 59.04%
Net Earnings / Revenue
Basic Earnings Per Share -$0.61
Diluted Earnings Per Share -$614.7K -$414.9K -$411.2K
COMMON SHARES
Basic Shares Outstanding 36.76M
Diluted Shares Outstanding 36.71M

Balance Sheet

Concept 2021 Q3 2020 Q4 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $236.2M $287.3M $191.5M
YoY Change 23.32% 29.13% -17.81%
Cash & Equivalents $149.0M $287.3M $191.5M
Short-Term Investments $87.12M $0.00
Other Short-Term Assets $8.732M $6.600M $4.000M
YoY Change 118.3% 100.0% 21.21%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $244.9M $293.9M $195.5M
YoY Change 25.29% 30.04% -17.4%
LONG-TERM ASSETS
Property, Plant & Equipment $8.269M $2.675M $4.300M
YoY Change 92.3% 6.49% 121.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $569.0K $200.0K $200.0K
YoY Change 184.5% 0.0% 0.0%
Total Long-Term Assets $8.838M $3.995M $4.400M
YoY Change 100.86% 47.04% 104.94%
TOTAL ASSETS
Total Short-Term Assets $244.9M $293.9M $195.5M
Total Long-Term Assets $8.838M $3.995M $4.400M
Total Assets $253.8M $297.9M $199.9M
YoY Change 26.95% 30.24% -16.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $655.0K $1.495M $1.100M
YoY Change -40.45% 99.07% -38.51%
Accrued Expenses $10.90M $8.500M $5.400M
YoY Change 101.87% 157.58% 74.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.88M $11.43M $6.700M
YoY Change 77.37% 178.59% 36.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.374M $400.0K $700.0K
YoY Change 524.86% 100.0% 250.0%
Total Long-Term Liabilities $4.374M $422.0K $700.0K
YoY Change 524.86% 90.95% 207.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.88M $11.43M $6.700M
Total Long-Term Liabilities $4.374M $422.0K $700.0K
Total Liabilities $16.26M $11.85M $7.400M
YoY Change 119.7% 174.11% 43.86%
SHAREHOLDERS EQUITY
Retained Earnings -$110.3M
YoY Change 90.02%
Common Stock $4.000K
YoY Change 33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $237.5M $286.1M $192.5M
YoY Change
Total Liabilities & Shareholders Equity $253.8M $297.9M $199.9M
YoY Change 26.95% 30.24% -16.3%

Cashflow Statement

Concept 2021 Q3 2020 Q4 2020 Q3
OPERATING ACTIVITIES
Net Income -$22.60M -$14.56M -$13.68M
YoY Change 65.13% 43.32% 59.04%
Depreciation, Depletion And Amortization $254.0K $240.0K $230.0K
YoY Change 10.43% 71.43% 91.67%
Cash From Operating Activities -$14.68M -$10.93M -$10.87M
YoY Change 35.07% 7.05% 35.2%
INVESTING ACTIVITIES
Capital Expenditures -$273.0K -$90.00K -$270.0K
YoY Change 1.11% -84.21% -54.24%
Acquisitions
YoY Change
Other Investing Activities -$4.991M $0.00 $0.00
YoY Change
Cash From Investing Activities -$5.264M -$90.00K -$270.0K
YoY Change 1849.63% -83.93% -54.24%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 408.0K 106.9M 670.0K
YoY Change -39.1% 56147.37% -167.0%
NET CHANGE
Cash From Operating Activities -14.68M -10.93M -10.87M
Cash From Investing Activities -5.264M -90.00K -270.0K
Cash From Financing Activities 408.0K 106.9M 670.0K
Net Change In Cash -19.54M 95.85M -10.47M
YoY Change 86.61% -1005.95% 8.72%
FREE CASH FLOW
Cash From Operating Activities -$14.68M -$10.93M -$10.87M
Capital Expenditures -$273.0K -$90.00K -$270.0K
Free Cash Flow -$14.41M -$10.84M -$10.60M
YoY Change 35.93% 12.45% 42.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:LiabilitiesNoncurrent
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M24D
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13684000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1785000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
682000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
352000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
175000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-21967000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-42000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4452000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
161000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
255069000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22597000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4614000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
73000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
334000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
237513000
us-gaap Profit Loss
ProfitLoss
-61357000
us-gaap Depreciation
Depreciation
739000
stok Amortization And Accretion Of Marketable Securities
AmortizationAndAccretionOfMarketableSecurities
86000
us-gaap Share Based Compensation
ShareBasedCompensation
11764000
us-gaap Share Based Compensation
ShareBasedCompensation
4188000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-29000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-3000
stok Reduction In Carrying Amount Of Operating Lease Right Of Use Assets
ReductionInCarryingAmountOfOperatingLeaseRightOfUseAssets
870000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2073000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-707000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50649000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31290000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
87226000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
997000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
960000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88223000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-960000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
509000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
352000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
605000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1248000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
360000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1113000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1240000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-137759000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31010000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
287513000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
222676000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
149754000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
191666000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
38000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
76000
stok Right Of Use Asset Recognized In Exchange For Operating Lease
RightOfUseAssetRecognizedInExchangeForOperatingLease
5081000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2153000
stok Deferred Offering Costs Not Yet Paid
DeferredOfferingCostsNotYetPaid
17000
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q3 stok Maximum Aggregate Offering Price
MaximumAggregateOfferingPrice
400000000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity, expenses and disclosure of contingent assets and liabilities. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. Actual results could differ from those estimates. </p>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
149038000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191461000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
147000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
569000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
205000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
149754000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
191666000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
87140000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
22000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
87118000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3496000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4123000
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
518000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
593000
CY2021Q3 stok Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
5434000
CY2020Q4 stok Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3689000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1425000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
82000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
328000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1443000
CY2021Q3 stok Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
11229000
CY2020Q4 stok Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
9930000
CY2018Q3 stok Area Of Space Subject To Operating Lease
AreaOfSpaceSubjectToOperatingLease
23000
CY2018Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2018Q3 stok Operating Lease Cost Per Year
OperatingLeaseCostPerYear
900000
CY2018Q3 stok Annual Base Rent Increase Percentage For Operating Lease
AnnualBaseRentIncreasePercentageForOperatingLease
0.03
CY2018Q3 stok Operating Lease Commencement Date
OperatingLeaseCommencementDate
2018-12-10
CY2018Q4 stok Area Of Space Subject To Operating Lease
AreaOfSpaceSubjectToOperatingLease
2485
CY2018Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2018Q4 stok Number Of Renewal Option To Extend Operating Lease Terms
NumberOfRenewalOptionToExtendOperatingLeaseTerms
1
CY2018Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2018Q4 stok Operating Lease Cost Per Year
OperatingLeaseCostPerYear
200000
CY2018Q4 stok Annual Base Rent Increase Percentage For Operating Lease
AnnualBaseRentIncreasePercentageForOperatingLease
0.025
CY2018Q4 stok Operating Lease Commencement Date
OperatingLeaseCommencementDate
2019-05-01
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
364000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2124000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2532000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2608000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
173000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7801000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
519000
CY2021Q3 stok Lessee Operating Lease Liability Present Value
LesseeOperatingLeaseLiabilityPresentValue
7282000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1102000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
81000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1183000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
37000
CY2020Q4 stok Lessee Operating Lease Liability Present Value
LesseeOperatingLeaseLiabilityPresentValue
1146000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5326000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1425000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5340000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0414
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
48700000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
48700000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y7D
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4614000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1785000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11764000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4188000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-22597000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-13684000
us-gaap Net Income Loss
NetIncomeLoss
-61357000
us-gaap Net Income Loss
NetIncomeLoss
-37682000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36759319
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
33273597
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36706647
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
32954727
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.41
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.67
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.14
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
37200000
CY2020Q1 stok Percentage Of Net Operating Loss Carryovers And Carrybacks To Offset Of Taxable Income Cares Act
PercentageOfNetOperatingLossCarryoversAndCarrybacksToOffsetOfTaxableIncomeCARESAct
1
CY2020Q1 stok Percentage Of Net Operating Loss Carryovers And Carrybacks To Offset Of Taxable Income Cares Act
PercentageOfNetOperatingLossCarryoversAndCarrybacksToOffsetOfTaxableIncomeCARESAct
1
CY2021Q3 stok Income Taxes Receivable Net Operating Loss Cares Act
IncomeTaxesReceivableNetOperatingLossCARESAct
0
CY2021Q3 stok Income Taxes Receivable Net Operating Loss Cares Act
IncomeTaxesReceivableNetOperatingLossCARESAct
0
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0

Files In Submission

Name View Source Status
0001564590-21-055240-index-headers.html Edgar Link pending
0001564590-21-055240-index.html Edgar Link pending
0001564590-21-055240.txt Edgar Link pending
0001564590-21-055240-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gw21bqpfrkyv000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stok-10q_20210930.htm Edgar Link pending
stok-10q_20210930_htm.xml Edgar Link completed
stok-20210930.xsd Edgar Link pending
stok-20210930_cal.xml Edgar Link unprocessable
stok-20210930_def.xml Edgar Link unprocessable
stok-20210930_lab.xml Edgar Link unprocessable
stok-20210930_pre.xml Edgar Link unprocessable
stok-ex101_235.htm Edgar Link pending
stok-ex102_236.htm Edgar Link pending
stok-ex311_6.htm Edgar Link pending
stok-ex312_7.htm Edgar Link pending
stok-ex321_10.htm Edgar Link pending
stok-ex322_8.htm Edgar Link pending